馬歇爾大學(xué)的Eric Blough及其同事發(fā)現(xiàn)，常用的止痛藥乙酰氨基酚或許能夠防止因衰老引起的肌肉損失,。
蛋白激酶B在調(diào)節(jié)細(xì)胞的生長(zhǎng),，增殖以及代謝的生物過(guò)程中具有重要作用,，該課題組研究了乙酰氨基酚如何影響蛋白激酶B (Akt)的調(diào)節(jié)作用。
研究數(shù)據(jù)表明,，骨骼肌在衰老過(guò)程中,，發(fā)揮某些功能的酶會(huì)逐漸減少，而乙酰氨基酚能使老齡動(dòng)物的Akt活性水平恢復(fù)到與年輕動(dòng)物相同的水平,。Akt活性的提高反過(guò)來(lái)也能影響肌肉細(xì)胞的大小,，并降低肌肉細(xì)胞的死亡。
該研究報(bào)告發(fā)表在7月29日PLoS ONE雜志上,，首次研究了動(dòng)物攝入乙酰氨基酚,，能夠用于治療衰老引起的肌肉損失,。
據(jù)研究人員Miaozong Wu介紹，乙酰氨基酚在體內(nèi)能夠降低活性氧的含量,，若體內(nèi)聚集大量的活性氧將引起多種衰老相關(guān)的疾病,，因此，該研究或許可以為減緩衰老提供新的途徑,。（生物谷Bioon.com）
生物谷推薦原始出處：
PLoS ONE 4(7): e6430. doi:10.1371/journal.pone.0006430
Aging-Associated Dysfunction of Akt/Protein Kinase B: S-Nitrosylation and Acetaminophen Intervention
Miaozong Wu1,2, Anjaiah Katta3, Murali K. Gadde1,2, Hua Liu1,2,5, Sunil K. Kakarla3, Jacqueline Fannin3, Satyanarayana Paturi1,2, Ravi K. Arvapalli1,2, Kevin M. Rice1,2,4, Yeling Wang1,2,6, Eric R. Blough1,2,3,4*
1 Department of Biological Sciences, Marshall University, Huntington, West Virginia, United States of America, 2 Cell Differentiation and Development Center, Marshall University, Huntington, West Virginia, United States of America, 3 Department of Pharmacology, Physiology and Toxicology, Marshall University, Huntington, West Virginia, United States of America, 4 Department of Exercise Science, Sport and Recreation, Marshall University, Huntington, West Virginia, United States of America, 5 Department of Physiology and Pharmacology, Southeast University, Nanjing, China, 6 The First Hospital, Jilin University, Jilin, China
Background
Aged skeletal muscle is characterized by an increased incidence of metabolic and functional disorders, which if allowed to proceed unchecked can lead to increased morbidity and mortality. The mechanism(s) underlying the development of these disorders in aging skeletal muscle are not well understood. Protein kinase B (Akt/PKB) is an important regulator of cellular metabolism and survival, but it is unclear if aged muscle exhibits alterations in Akt function. Here we report a novel dysfunction of Akt in aging muscle, which may relate to S-nitrosylation and can be prevented by acetaminophen intervention.
Principal Findings
Compared to 6- and 27-month rats, the phosphorylation of Akt (Ser473 and Thr308) was higher in soleus muscles of very aged rats (33-months). Paradoxically, these increases in Akt phosphorylation were associated with diminished mammalian target of rapamycin (mTOR) phosphorylation, along with decreased levels of insulin receptor beta (IR-β), phosphoinositide 3-kinase (PI3K), phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and phosphorylation of phosphoinositide-dependent kinase-1 (PDK1) (Ser241). In vitro Akt kinase measurements and ex vivo muscle incubation experiments demonstrated age-related impairments of Akt kinase activity, which were associated with increases in Akt S-nitrosylation and inducible nitric oxide synthase (iNOS). Impairments in Akt function occurred parallel to increases in myocyte apoptosis and decreases in myocyte size and the expression of myosin and actin. These age-related disorders were attenuated by treating aged (27-month) animals with acetaminophen (30 mg/kg body weight/day) for 6-months.
Conclusions
These data demonstrate that Akt dysfunction and increased S-nitrosylation of Akt may contribute to age-associated disorders in skeletal muscle and that acetaminophen may be efficacious for the treatment of age-related muscle dysfunction.
